REGENXBIO Inc — Quarterly Financial Data (NASDAQ:RGNX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notizie

Stifel commenta le azioni uniQure dopo le dichiarazioni del commissario FDA

Stifel comments on uniQure shares after FDA commissioner remarks

Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com

REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)

Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection

Intel, Wells Fargo among market cap stock movers on Tuesday

Netflix and Oracle among market cap stock movers on Tuesday

Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback

Titoli dopo la chiusura: ON Semiconductor, Credo, Upwork, Regenxbio e altri

Il titolo REGENXBIO crolla dopo il rifiuto della FDA per la terapia genica